Effectiveness of Active Exploration of Simulated Textures for Sensorimotor Recovery (NCT06962397) | Clinical Trial Compass
RecruitingNot Applicable
Effectiveness of Active Exploration of Simulated Textures for Sensorimotor Recovery
Russia20 participantsStarted 2024-10-08
Plain-language summary
Parallel-group, single-blinded controlled clinical trial. The study includes people aged 18-80 years, more than one month after stroke, with confirmed diagnosis, MoCA ≥ 20, and Barthel Index ≥ 3.
The control group receives standard rehabilitation. The experimental group also receives active sensory training with programmable electrical stimulation to simulate virtual textures.
Sensory function was assessed before and after the training using standard tests, including Fugl-Meyer, ARAT, 9HPT, and monofilament testing.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Episode of stroke confirmed by neuroimaging
* More than one month post-stroke
* Montreal Cognitive Assessment (MoCA) score ≥ 20
* Barthel Index score ≥ 3
* Ability to understand and follow instructions
* Informed consent for participation and data collection
* Age 18-80 years
Exclusion Criteria:
* Presence of depressive symptoms (HADS-Depression \> 11)
* Upper limb paresis score below 35 on the Fugl-Meyer scale
* Sensory impairment score below 3 or above 10 on the Fugl-Meyer scale
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Tactile Sensitivity of the Affected Index Finger
Timeframe: From enrollment to the end of treatment at 2 weeks
Trial details
NCT IDNCT06962397
SponsorFederal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health